NRC Health
- Last sale
- Nov 12, 2026 · -0.47%
- Market cap
- $566.40M
- 21.22M shares
- Filings
- 1,010
Q3 2026−4.0% FY25 yoy
Q3 2026−53.2% FY25 yoy
Q3 2026−35.8% FY25 yoy
Q3 2026derived−17.9% FY25 yoy
Q3 2026+4,707.7% FY25 yoy
Q3 2026−2.2% FY25 yoy
- $566.40M
- 88.0×
- 3.9×
- —
- 3.26%
- 2.38%
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $137,390,000 | reported | |
| FY 2024 | 2024-12-31 | $143,060,000 | reported | |
| FY 2023 | 2023-12-31 | $148,580,000 | reported | |
| FY 2022 | 2022-12-31 | $151,568,000 | reported | |
| FY 2021 | 2021-12-31 | $147,954,000 | reported | |
| FY 2020 | 2020-12-31 | $133,277,000 | reported | |
| FY 2019 | 2019-12-31 | $127,982,000 | reported | |
| FY 2018 | 2018-12-31 | $119,686,000 | reported | |
| FY 2017 | 2017-12-31 | $117,559,000 | reported | |
| FY 2016 | 2016-12-31 | $109,384,000 | reported | |
| FY 2015 | 2015-12-31 | $102,343,000 | reported | |
| FY 2014 | 2014-12-31 | $98,837,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | $10.98M | $20.18M | $31.16M | $0.52 | 22.54M sh | −1.8% | 197.9% |
| FY2024 | $11.45M | $30.95M | $42.40M | $0.48 | 22.95M sh | −3.8% | 221.1% |
| FY2023 | $36.37M | $19.10M | $55.47M | $1.48 | 23.85M sh | −3.0% | 248.3% |
| FY2022 | $20.96M | $27.62M | $48.58M | $0.84 | 24.59M sh | −2.4% | 183.8% |
| FY2021 | $9.16M | $4.14M | $13.30M | $0.48 | 25.19M sh | −1.0% | 32.6% |
Segments
Geography
LineFY2024ShareChange
UNITED STATES$143.06M100%−3.7%
CANADA$0.00——
Total$143.06M
Commercial physical & biological research
NRC Health is the 6th largest of the 17 covered companies the SEC files under this code, by revenue. SIC 8731
CompanyRevenueGrowthNet marginMarket cap
INCYIncyte Corp$5.1B21.2%25.0%$24.8BCRLCharles River Laboratories International, Inc.$4.0B0.9%3.6%$16.9BMEDPMedpace Holdings, Inc.$2.5B20.0%17.8%$18.4B
NRCNRC Health (this company)$137.4M4.0%8.4%$566.4M
MXCTMaxcyte, Inc.$33.0M14.5%135.1%$121.8MOABIOmniAb, Inc.$18.7M29.3%347.0%$721.3MFOXOFoxo Technologies Inc.$16.4M304.0%75.9%—BIAFbioAffinity Technologies, Inc.$6.2M34.2%242.0%$4.3MABSIAbsci Corp$2.8M38.2%4,113.7%$1.6BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
NRC Health · CIK 70487 · Engraved from SEC EDGAR